 prognost factor invas bladder carcinoma prospect trial preoper adjuv chemotherapi clinic patholog factor patient local muscle-invas bladder carcinoma prospect bladder-preserv program consist transurethr tumor resect neoadjuv chemotherapi methotrex cisplatin vinblastin mcv cgi radiotherapi concurr cisplatin patient biopsy-proven complet respons chemotherapi cgi radiat full-dos radiotherapi cgi cisplatin cystectomi patient residu diseas distant metastasi rate tumor stage size patient patient tumor cm tumor equal cm risk bladder tumor recurr patient tumor-associ carcinoma situ ci ci papillari tumor solid tumor similar treatment outcom multivari analysi tumor stage absenc ci signific predictor complet respons ci predict local bladder recurr size respons chemoradiotherapi vascular invas distant metastasi local bladder tumor recurr superfici tumor low actuari distant metastasi rate patient year actuari overal surviv rate patient similar treatment outcom papillari versu solid tumor publish histor control result preliminari evid median follow-up month current chemoradiotherapi regimen benefici effect treatment muscle-invas bladder carcinoma true efficaci neoadjuv chemotherapi trial